These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35987411)

  • 1. Mechanisms of Xiong-Pi-Fang in treating coronary heart disease associated with depression: A systematic pharmacology strategy and in vivo pharmacological validation.
    Deng F; Li X; Tang C; Chen J; Fan B; Liang J; Zhen X; Tao R; Zhang S; Cong Z; Du W; Zhao H; Xu L
    J Ethnopharmacol; 2022 Nov; 298():115631. PubMed ID: 35987411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Integrative Pharmacology-Based Strategy to Uncover the Mechanism of Xiong-Pi-Fang in Treating Coronary Heart Disease with Depression.
    Zhang L; Zhang Y; Zhu M; Pei L; Deng F; Chen J; Zhang S; Cong Z; Du W; Xiao X
    Front Pharmacol; 2021; 12():590602. PubMed ID: 33867976
    [No Abstract]   [Full Text] [Related]  

  • 3. Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression.
    Nikkheslat N; Zunszain PA; Horowitz MA; Barbosa IG; Parker JA; Myint AM; Schwarz MJ; Tylee AT; Carvalho LA; Pariante CM
    Brain Behav Immun; 2015 Aug; 48():8-18. PubMed ID: 25683698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the pharmacodynamic substances and possible mechanism of Trichosanthis Pericarpium in the treatment of coronary heart disease based on plasma pharmacochemistry, network pharmacology and experimental validation.
    Zhang XY; Xia KR; Wang YN; Liu P; Shang EX; Liu CY; Liu YP; Qu D; Li WW; Duan JA; Chen Y; Zhang HQ
    J Ethnopharmacol; 2024 May; 325():117869. PubMed ID: 38342153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Xuefu Zhuyu Decoction in the treatment of coronary heart disease based on integrated metabolomics and network pharmacology approach.
    Yang Y; Su C; Zhang XZ; Li J; Huang SC; Kuang HF; Zhang QY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1223():123712. PubMed ID: 37060624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.
    Mao X; Xu H; Li S; Su J; Li W; Guo Q; Wang P; Guo R; Xiao X; Zhang Y; Yang H
    Phytomedicine; 2019 Feb; 54():159-168. PubMed ID: 30668365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning.
    Yang J; Tian S; Zhao J; Zhang W
    Pharmacol Res; 2020 Sep; 159():105034. PubMed ID: 32565312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.
    Zhang YQ; Guo QY; Li QY; Ren WQ; Tang SH; Wang SS; Liang RX; Li DF; Zhang Y; Xu HY; Yang HJ
    Acta Pharmacol Sin; 2018 Jun; 39(6):975-987. PubMed ID: 28858293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrative metabolomics and network pharmacology method for exploring the effect and mechanism of Radix Bupleuri and Radix Paeoniae Alba on anti-depression.
    Zhang H; Zhang S; Hu M; Chen Y; Wang W; Zhang K; Kuang H; Wang Q
    J Pharm Biomed Anal; 2020 Sep; 189():113435. PubMed ID: 32653815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network pharmacology analysis and experimental verification of the antithrombotic active compounds of trichosanthis pericarpium (Gualoupi) in treating coronary heart disease.
    Xia KR; Zhang XY; Zhang HQ; Su KL; Shang EX; Xiao QL; Li WW; Guo S; Duan JA; Liu P
    J Ethnopharmacol; 2024 Jul; 329():118158. PubMed ID: 38614263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect and mechanism of Jiao-tai-wan in the treatment of diabetes mellitus with depression based on network pharmacology and experimental analysis.
    Tang Y; Su H; Wang H; Lu F; Nie K; Wang Z; Huang W; Dong H
    Mol Med; 2021 Dec; 27(1):154. PubMed ID: 34875999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula for coronary heart disease.
    Ma X; Wang Q; Liu C; Liu J; Luo G; He L; Yuan T; He RR; Yao Z
    Phytomedicine; 2023 Jun; 114():154749. PubMed ID: 36931097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ro41-5253, a selective antagonist of retinoic acid receptor α, ameliorates chronic unpredictable mild stress-induced depressive-like behaviors in rats: Involvement of regulating HPA axis and improving hippocampal neuronal deficits.
    Ke Q; Li R; Cai L; Wu SD; Li CM
    Brain Res Bull; 2019 Mar; 146():302-309. PubMed ID: 30711623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncovering the molecular mechanisms of Fructus Choerospondiatis against coronary heart disease using network pharmacology analysis and experimental pharmacology.
    Gao X; Zhang Y; Li T; Li J; Su Y; Wang H; Yan Z; Qin K
    Anal Biochem; 2023 Aug; 675():115214. PubMed ID: 37353066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
    Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification.
    Ding P; Liu J; Li Q; Lu Q; Li J; Shi R; Shi L; Mao T; Ge D; Niu H; Peng G; Wang Z
    Drug Des Devel Ther; 2021; 15():4259-4273. PubMed ID: 34675488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network pharmacology provides a systematic approach to understanding the treatment of ischemic heart diseases with traditional Chinese medicine.
    Yang HY; Liu ML; Luo P; Yao XS; Zhou H
    Phytomedicine; 2022 Sep; 104():154268. PubMed ID: 35777118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of protective effect of xuan-bai-cheng-qi decoction on LPS-induced acute lung injury based on an integrated network pharmacology and RNA-sequencing approach.
    Zhu H; Wang S; Shan C; Li X; Tan B; Chen Q; Yang Y; Yu H; Yang A
    Respir Res; 2021 Jun; 22(1):188. PubMed ID: 34183011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the active compounds and mechanism of action of Banxia Xiexin decoction for treating ethanol-induced chronic gastritis using network pharmacology combined with UPLC-LTQ-Orbitrap MS.
    Ji W; Wang T; Xu Y; An R; Liang K; Wang X
    Comput Biol Chem; 2021 Aug; 93():107535. PubMed ID: 34217946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering the active components, prospective targets, and molecular mechanism of Baihe Zhimu decoction for treating depression using network pharmacology-based analysis.
    Wang HQ; Liu HT; Wang L; Min L; Chen B; Li H
    J Ethnopharmacol; 2021 Dec; 281():114586. PubMed ID: 34464700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.